Femasys (FEMY) EBITDA Margin Growth (3y) (2023 - 2025)
Femasys (FEMY) EBITDA Margin Growth (3y) (2023 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.49 Bn | 129.28 Bn | 1.96 Bn | 722.00 |
| 2 | Becton Dickinson | 52.54 Bn | 51.67 Bn | 2.32 Bn | 205.00 |
| 3 | Alcon | 35.71 Bn | 34.35 Bn | 1.68 Bn | -2,360.00 |
| 4 | Resmed | 33.80 Bn | 32.33 Bn | 861.22 Mn | 612.00 |
| 5 | Medline | 29.08 Bn | 26.40 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 24.96 Bn | 24.52 Bn | 329.20 Mn | -368.00 |
| 7 | Solventum | 15.40 Bn | 15.00 Bn | 1.29 Bn | -1,189.00 |
| 8 | Cooper Companies | 14.82 Bn | 14.68 Bn | 735.40 Mn | -1,384.00 |
| 9 | Baxter International | 13.61 Bn | 11.46 Bn | 1.03 Bn | 799.00 |
| 10 | Femasys | 9.60 Mn | 8.16 Mn | 189,391.00 | -61,064.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -6,354.00 |
| Mar 31, 2025 | -70,319.00 |
| Dec 31, 2024 | 11,502.00 |
| Sep 30, 2024 | -8,723.00 |
| Jun 30, 2024 | -144,055.00 |
| Mar 31, 2024 | -72,319.00 |
| Dec 31, 2023 | -149,547.00 |
| Sep 30, 2023 | -117,055.00 |
| Jun 30, 2023 | -10,632.00 |